NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Allele Biotechnology and Pharmaceuticals, Inc.

Allele Biotechnology and Pharmaceuticals, Inc.

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://allelebiotech.com/

Last Round

Grant

Jan 14, 2026

Total Funding Raised

$7M

Company Overview

Allele Biotechnology and Pharmaceuticals, Inc. is a biotechnology company that develops mRNA-based reprogramming technologies, cGMP-grade induced pluripotent stem cell (iPSC) lines, and specialized CDMO services for regenerative medicine and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

contract research organizationCROcontract development and manufacturing organizationCDMOstem cell researchiPSC generationfluorescent proteinmNeonGreennanobody developmentgene editingCRISPRantibody humanizationbiotech reagentsdrug discovery servicescell engineeringbench sciencewet lab services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allele Biotechnology and Pharmaceuticals, Inc. Comparables

Compare Allele Biotechnology and Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.

Allele Biotechnology and Pharmaceuticals, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iXCells Biotechnologies
84%
Applied StemCell, Inc.
79%
NanoTag Biotechnologies
77%

Allele Biotechnology and Pharmaceuticals, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 14, 2026
GrantOct 15, 2018
Series ASep 25, 2014

Allele Biotechnology and Pharmaceuticals, Inc. Investors

Notable investors and investment history

Allele Biotechnology and Pharmaceuticals, Inc. investors
InvestorRounds
ARPA-HGrant
National Institute of General Medical SciencesGrant
Yifang Technology GroupSeries A

Allele Biotechnology and Pharmaceuticals, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Allele Biotechnology and Pharmaceuticals, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allele Biotechnology and Pharmaceuticals, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range29
Year Founded1999
Last FundingJan 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.